The anti-doping agency in Italy have appealed to lengthen the two months ban handed to former French Open finalist Sara Errani.
NADO Italia – which operates independently from the Italian Olympic Committee filed a “statement of appeal” with the Court of Arbitration for Sport (CAS), without specifying how lengthy they want the ban to be extended.
On August 7th, 2017, it was announced that Sara Errani will be suspended for two months due to failing a doping test. She tested positive for the prohibited substance Letrozole, which is used for the treatment of hormonally-responsive breast cancer after surgery.
However, Errani claimed that she likely ingested letrozole by “accidentally consuming her mother’s anti-cancer medication Femara” while visiting her family.
An International Tennis Federation adjudication panel ruled that Errani’s fault was “at the lower end of the scale.”
As a result of her being suspended for two months, All her results from the date of her positive out-of-competition test on February 16th until a negative test on June 7th have been annulled; all ranking points and prize money accrued in this period have had to be forfeited.
Her suspension for two months will end on October 2nd 2017.